Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. According to a Specialized Nutrition Europe study, nearly 40% of hospitalized adult patients were malnourished in Europe in 2019. Nutritional support delivered through enteral & parenteral means, depending on the need, is an important and appropriate way of treating most malnutrition cases. Thus, the huge burden of malnutrition in children and adults drives the demand for enteral and parenteral nutrition formulae and products. Preterm birth refers to a baby being born too early, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm birth (more than 1 in 10 births) were reported worldwide in 2020. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe, also parenteral nutrition is preferred in such babies due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. Hence, with the high number of preterm births, the demand for enteral and parenteral medical nutrition is on the rise in the region.
The Europe enteral and parenteral medical nutrition market is segmented into Germany, the UK, France, Italy, Spain, Poland, Switzerland, Sweden, Belgium, the Netherlands, and the Rest of Europe. Europe occupies a significant position in the Europe enteral and parenteral medical nutrition market and is estimated to register a robust growth rate over the forecast period. The market growth can be attributed to increasing geriatric population, rising incidence of chronic diseases and neurological disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region.
Europe Enteral and Parenteral Medical Nutrition Market Segmentation
The Europe enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.
Based on indication, the Europe enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.
Based on nutrition type, the Europe enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the Europe enteral and parenteral medical nutrition market in 2023.
Based on form, the Europe enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.
Based on product type, the Europe enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.
Based on route of administration, the Europe enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.
Based on age group, the Europe enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.
Based on distribution channel, the Europe enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023
Based on country, the Europe enteral and parenteral medical nutrition market is segmented into Germany, the UK, France, Italy, Spain, Poland, Switzerland, Sweden, Belgium, the Netherlands, and the Rest of Europe. Germany dominated the share of the Europe enteral and parenteral medical nutrition market in 2023.
Abbott Laboratories; AYMES International Ltd; B. Braun SE; Baxter International Inc; Charing Cross Scientific AS; Fresenius Kabi AG; Medifood International SA; Nestle SA; Nutricia International BV; and Smartfish AS are some of the leading companies operating in the Europe enteral and parenteral medical nutrition market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 6,472.35 Million |
| Market Size by 2028 | US$ 9,054.89 Million |
| CAGR (2023 - 2028) | 6.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Indication
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Enteral and Parenteral Medical Nutrition Market is valued at US$ 6,472.35 Million in 2023, it is projected to reach US$ 9,054.89 Million by 2028.
As per our report Europe Enteral and Parenteral Medical Nutrition Market, the market size is valued at US$ 6,472.35 Million in 2023, projecting it to reach US$ 9,054.89 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Enteral and Parenteral Medical Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Enteral and Parenteral Medical Nutrition Market report:
The Europe Enteral and Parenteral Medical Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Enteral and Parenteral Medical Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Enteral and Parenteral Medical Nutrition Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Europe Enteral and Parenteral Medical Nutrition Market
